Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.

Breast cancer research and treatment - 1 Mar 2003

Claus Elizabeth B, Stowe Meredith, Carter Darryl

Abstract excerpt

UNLABELLED: A family history of breast cancer is an important risk factor for breast carcinoma in situ (BCIS), however, there are no detailed analyses of its variation in effect by number, type, laterality or age at onset of affected relatives nor by association with ovarian cancer. In addition, the role of the breast cancer susceptibility genes, BRCA1 and BRCA2, in the development of BCIS is unclear. OBJECTIVE:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Lobular

Share to Case-Control Studies

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 12611452
DOI: 10.1023/a:1022147920262

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.PMID 12611452Read ↗

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.Semantic proximity Read ↗

Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.Semantic proximity Read ↗

Emerging Trends in Family History of Breast Cancer and Associated Risk.Semantic proximity Read ↗

Genetic risk variants associated with in situ breast cancer.Semantic proximity Read ↗

Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.Semantic proximity Read ↗

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Semantic proximity Read ↗

Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.Semantic proximity Read ↗

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.Semantic proximity Read ↗

BRCA mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

Ductal carcinoma in situ in BRCA mutation carriers.Semantic proximity Read ↗

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.